Attendees will gain insight into the Company’s clinical trials, partnership network, and growth plans VANCOUVER, BC, Oct. 12, 2022 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, today announced that it will host a virtual update for investors and shareholders on Wednesday, October 19…
